RETA, GLP-3 (R) – 10mg

RETA, GLP-3 (R) is a Triple–Hormone-Receptor Agonist.

GLP-3 (R) is a cutting-edge investigational peptide that functions as a triple agonist targeting GLP-1, GIP, and glucagon receptors. It has shown remarkable potential in preclinical and clinical studies for reducing body fat, regulating glucose levels, and enhancing overall metabolic performance. Retatrutide offers a powerful, multi-pathway approach to managing obesity and type 2 diabetes, making it one of the most promising compounds in metabolic research.

Properties

• Chemical Name: GLP-3 (R)

• CAS Number: 2381089-83-2

• Molecular Target: GLP-1R / GIPR / Glucagon receptor

• Form: Lyophilized (freeze-dried) peptide powder

• Strength: 10mg per vial

• Appearance: White to off-white powder

• Storage:

  • Before reconstitution: Store at room temperature for up to 30 days or in the freezer at -20°C for long-term storage.

  • After reconstitution: Store in the refrigerator (2–8°C) and use within 60 days.

Benefit

• Supports fat loss through appetite suppression and energy expenditure

• Enhances insulin sensitivity and glucose regulation

• Activates multiple metabolic pathways for synergistic effects

• Promising outcomes in preclinical studies for obesity and diabetes

• May improve lipid profile and reduce inflammation

Dosage

The initial dose of GLP-3 (R) is 1 mg, which is injected subcutaneously once weekly. The dose of the drug can be increased to 2 mg, 4 mg, or 8mg after 4 weeks, depending on the patient’s response. The maximum dose is 12 mg per week.

The initial dose of retatrutide is important because it helps to minimize the risk of side effects. If the patient tolerates the initial dose well, the dose can be increased gradually. However, if the patient experiences any serious side effects, the dose of the drug should be reduced or discontinued.